The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases. - Pach J; Valido K; Belzer A; Leventhal JS (American journal of clinical dermatology, 2024)